Article
Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.
Journal of clinical microbiology - 1 Sept 2018
Green Luke R, Lucidarme Jay, Dave Neelam, Chan Hannah, Clark Stephen, Borrow Ray, Bayliss Christopher D
Abstract excerpt
A recombinant NadA protein is one of the four major protective antigens of 4C-MenB (Bexsero), a vaccine developed for serogroup B Neisseria meningitidis (MenB). The meningococcal antigen typing system (MATS) is utilized as a high-throughput assay for assessing the invasive MenB strain coverage of 4C-MenB. Where present, the nadA gene is subject to phase-variable changes in transcription due to a 5'TAAA repeat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
